Cks1brt, a retrogene encoding CDC28 protein kinase 1b, is implicated in crucial cellular processes, including the regulation of the mitotic cell cycle. Predicted to possess cyclin-dependent protein serine/threonine kinase activator activity, histone binding activity, and ubiquitin binding activity, Cks1brt plays a central role in coordinating the progression of cells through the cell cycle. The activation of Cks1brt involves intricate interactions with various chemicals that modulate specific cellular pathways. Roscovitine, a CDK inhibitor, directly inhibits CDKs, leading to the down-regulation of Cks1brt-associated mitotic cell cycle regulation. MG-132, a proteasome inhibitor, indirectly up-regulates Cks1brt by preventing its degradation via the ubiquitin-proteasome system, promoting mitotic cell cycle regulation. SB203580, an inhibitor of p38 MAPK, influences the MAPK pathway, indirectly affecting Cks1brt and its role in mitotic cell cycle regulation. LY294002, a PI3K inhibitor, modulates the PI3K signaling pathway, indirectly impacting Cks1brt and its involvement in mitotic cell cycle regulation. Thymoquinone, an anti-inflammatory compound, indirectly influences Cks1brt by affecting pathways related to mitotic cell cycle regulation. Purvalanol A, a CDK inhibitor, directly inhibits CDKs, leading to down-regulation of Cks1brt-associated mitotic cell cycle regulation.
Wortmannin, another PI3K inhibitor, modulates the PI3K signaling pathway, indirectly impacting Cks1brt and its involvement in mitotic cell cycle regulation. SP600125, a JNK inhibitor, affects the JNK pathway, indirectly influencing Cks1brt and its role in mitotic cell cycle regulation. Resveratrol, an activator of SIRT1, indirectly up-regulates Cks1brt by modulating the SIRT1 pathway, potentially influencing mitotic cell cycle regulation. Nocodazole, a microtubule inhibitor, indirectly influences Cks1brt by disrupting microtubule dynamics, potentially impacting mitotic cell cycle regulation. PD98059, a MEK inhibitor, modulates the MAPK pathway, indirectly influencing Cks1brt and its role in mitotic cell cycle regulation. In summary, Cks1brt emerges as a key player in the intricate machinery of cell cycle regulation, and its activation is intricately linked to the modulation of various cellular pathways. The diverse range of chemicals influencing Cks1brt highlights its significance in ensuring proper mitotic cell cycle progression and positions it as a potential target for further investigations in cellular and molecular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Cyclin-dependent kinase inhibitor. Directly inhibits CDKs, leading to the down-regulation of Cks1brt-associated mitotic cell cycle regulation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor. Indirectly up-regulates Cks1brt by preventing its degradation via the ubiquitin-proteasome system, promoting mitotic cell cycle regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. Influences the MAPK pathway, indirectly affecting Cks1brt and its role in mitotic cell cycle regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. Modulates the PI3K signaling pathway, indirectly impacting Cks1brt and its involvement in mitotic cell cycle regulation. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $47.00 $133.00 | 21 | |
Anti-inflammatory compound. Indirectly influences Cks1brt by affecting pathways related to mitotic cell cycle regulation. | ||||||
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $72.00 $297.00 | 4 | |
CDK inhibitor. Directly inhibits CDKs, leading to down-regulation of Cks1brt-associated mitotic cell cycle regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor. Modulates the PI3K signaling pathway, indirectly impacting Cks1brt and its involvement in mitotic cell cycle regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. Affects the JNK pathway, indirectly influencing Cks1brt and its role in mitotic cell cycle regulation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activator of SIRT1. Indirectly up-regulates Cks1brt by modulating the SIRT1 pathway, potentially influencing mitotic cell cycle regulation. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule inhibitor. Indirectly influences Cks1brt by disrupting microtubule dynamics, potentially impacting mitotic cell cycle regulation. | ||||||